You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窩輪》藥股回軟國泰破位留意石藥牛50767、國泰購20052
阿思達克 07-17 13:23

近日呈強的醫藥股,周三回軟。石藥集團(1093)跌幅逐步擴大至逾3%,回落至13.2元邊緣。觀望強勢股止跌回穩,看好可考慮石藥購13837,行使價16.88元,19年12月到期。或石藥牛50767,收回價12.28元,行使價11.58元,20年7月到期。相反看淡可留意石藥沽29015,行使價12.00元,19年12月到期。或石藥熊65172,收回價14.18元,行使價14.88元,20年2月到期。

同屬醫藥股的中國生物製藥(1177),周三亦曾跌近2%至8.8元以下。看好可考慮中藥購17344,行使價9.99元,19年10月到期。

早前發盈警的吉利汽車(0175),消化近期沽壓後反彈,高位升逾4%至12.3元以上,重上10天線。向上觀望重上20天線約12.7元的機會,支持參考11.5元。看好可留意吉利購19228,行使價13.20元,19年11月到期。或50兌1吉利牛62309,收回價10.28元,行使價9.78元,20年5月到期。相反看淡可留意吉利沽14111,行使價11.38元,19年9月到期。或50兌1吉利熊50947,收回價13.08元,行使價13.58元,20年1月到期。

油價下跌利好航空股走勢。國泰(0293)周三突破12元並升穿一個月高位,近期吸引資金開好倉。看好可留意國泰購20052,行使價12.54元,19年12月到期。中資航空股方面,東航(0670)周三升逾1%至4.6元以上,看好可留意東航購12182,行使價5.58元,20年5月到期。國航(0753)企穩8元,看好可留意國航購11159,行使價9.18元,19年9月到期。南航(1055)高位亦重上5.5元水平,看好可考慮南航購11158,行使價6.99元,19年12月到期。

(本結構性產品並無抵押品)

《瑞信香港認股證及牛熊證銷售主管何啟聰》

免責聲明:筆者為瑞士信貸(香港)有限公司的代表 ,並身為證監會持牌人,並無持有相關上市公司的任何財務權益。本文內容僅供參考,並不構成要約、建議或促使任何人士提呈買賣或認購任何證券。結構性產品價格可急升或急跌,投資者或會蒙受全盤損失。本產品並無抵押品。如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。牛熊證備強制贖回機制而可能被提早終止,屆時(i)N類牛熊證投資者將不獲發任何金額;而(ii)R類牛熊證之剩餘價值可能為零。有關恆生指數或恆生中國企業指數的免責聲明,請參閱上市文件。過往表現並不反映將來表現。投資前,投資者應瞭解風險,並諮詢專業顧問及查閱有關上市文件。瑞信之聯屬公司為結構性產品之流通量提供者,亦可能是唯一報價者。本文任何內容概不構成投資、法律、會計或稅務意見、並無聲明任何投資或策略適合或符合閣下的個別情況。結構性產品交投量並不是結構性產品表現的指標,投資者不應僅依賴交投量歷史高位數據以釐定結構性產品日後的表現。~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account